Skip to main content
Log in

Novel Antioxidants Zolimid and AEOL11201 Ameliorate Colitis in Rats

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

The mechanism of tissue damage in ulcerative colitis (UC) is unknown. However, recent evidence suggests that reactive oxygen species (ROS) are critical mediators of inflammation, and tissue damage in UC and antioxidants could be beneficial in the treatment of UC. Our aim was to evaluate the effects of two new antioxidants, Zolimid and AEOL11201 on experimental colitis. Antioxidants or vehicle were given to rats for five days after induction of colitis by intrarectal administration of 4% acetic acid. Severity of colitis was assessed on day 5. Zolimid and AEOL11201 significantly improved acetic acid-induced colitis. Both Zolimid and AEOL11201 significantly decreased the severity of diarrhea, and severity of macroscopic and histological changes in the colon. Both agents also significantly decreased colonic MPO levels. In conclusion, Zolimid and AEOL11201 are effective antiinflammatory agents in an animal model of colitis. Further studies are needed to evaluate their beneficial therapeutic effects in patients with UC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Kirsner JB, Shorter RG: Recent development in nonspecific inflammatory bowel disease. N Engl J Med 306:775–837, 1982

    Google Scholar 

  2. Babbs CF: Oxygen radicals in ulcerative colitis. Free Radic Biol Med 13:169–182, 1992

    Google Scholar 

  3. Grisham MB: Oxidants and free radicals in inflammatory bowel disease. Lancet 344:859–861, 1994

    Google Scholar 

  4. Sedgi S, Fields JZ, Klamut M, et al: Increased production of luminol enhanced chemiluminescence by the inflamed colonic mucosa in patients with ulcerative colitis. Gut 34:1191–1197, 1993

    Google Scholar 

  5. Simmonds NJ, Allen RE, Stevens TRJ, van Someren RNM, Blake DR, Rampton DS: Chemiluminescence assay of mucosal reactive metabolites in inflammatory bowel disease. Gastoenterology 103:186–196, 1992

    Google Scholar 

  6. Keshavarzian A, Sedghi S, Kanofsky J, et al: Excessive production of reactive oxygen metabolites by inflamed colon: Analysis by chemiluminescence probe. Gastroenterology 103,177–185, 1992

    Google Scholar 

  7. Grisham MB, Granger DN: Neutrophil mediated mucosal injury. Role of reactive oxygen metabolites. Dig Dis Sci 33(suppl):6S–15S, 1988

    Google Scholar 

  8. Keshavarzian A, et al: Mitomycin-C-induced colitis in rats: A new animal model of acute colonic inflammation implicating reactive oxygen species. J Lab Clin Med 120:778–791, 1992

    Google Scholar 

  9. Keshavarzian A, Morgan NG, Sedghi S., Gordon JH, Doria M: Role of reactive oxygen metabolites in experimental colitis. Gut 31:786–790, 1990

    Google Scholar 

  10. Emerit J, Pelletier S, Likforman J, Pasquier C, Thuillier A: Phase II trial of superoxide dismutase (CuZn SOD) in the treatment of crohn' disease. Free Radic Res Commun 12-13(Pt 2): 563–569, 1991

    Google Scholar 

  11. Levin KE, Pemberton JH, Phillips SF, Zinsmeister AR, Pezim ME: Role of oxygen free radicals in the etiology of pouchitis. Dis Colon Rectum 35:452–456, 1992

    Google Scholar 

  12. Keshavarzian A, Haydek J. Zabihi R, et al: Agents capable of eliminating reactive oxygen species. Catalase, WR-2721, or Cu(II)2(3,5-DIPS)4 decrease experimental colitis. Dig Dis Sci. 37(12):1866–1873, 1992

    Google Scholar 

  13. Yoshikawa T, Takahashi S, Kondo M: Possible role of free radicals in chronic inflammation in the gut. EXS 62:353–358, 1992

    Google Scholar 

  14. Simmonds NJ: Reactive oxygen metabolites and inflammatory bowel diseases. Doctor of Medicine, thesis. Oxford, Oxford University, 1992

    Google Scholar 

  15. Simmonds NJ, Blake DR, Rampton DS: The effects of amino salicylates and potential new drugs on mucosal reactive oxygen metabolite production in ulcerative colitis. Gut 33(suppl):S7, 1992

    Google Scholar 

  16. Yavuz Y, Yuksel M, Yegen BC. Alican I: The effect of antioxidant therapy on colonic inflammation in the rat. Res Exp Med 199(2):101–110, 1999

    Google Scholar 

  17. Koksoy FN, Kose H, Soybir GR, Yalcin O, Cockneseli B: The prophylactic effects of superoxide dismutase, catalase, desferrioxamine, verapamil and disulfuram in experimental colitis. J R Coll Surg Edinburgh 42(1):27–30, 1997

    Google Scholar 

  18. Viau AT, Abchowski A, Greenspan S, Davis FF: Safety evaluation of free radical scavengers PEG-catalase and PEGsuperoxide dismutase. J Free Radic Biol Med 2(4):283–288, 1986

    Google Scholar 

  19. MacPherson BR, Pfeiffer CJ: Experimental production of diffuse colitis in rats. Digestion 17:135–150, 1978

    Google Scholar 

  20. Millar AD, Rampton DS, Chander CL, Claxson AW, Blades S, Coumbe A, Panneta J, Morris CJ, Blake DR: Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis. Gut 39(3):407–415, 1996

    Google Scholar 

  21. Krawisz JE, Sharon P., Stenson WF: Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Gastroenterology 87:1344–1350, 1984

    Google Scholar 

  22. Babizhayev MA, Seguin MC, Gueyne J, Evstigneeva RP, Ageyeva EA, Zheltukhina GA: L-Carnosine(eta-alanyl-Lhistidine) and carcinine (beta-alanylhistamine) act as natural antixodiants with hyroxyl-radical-scavenging and lipid peroxidase activities. Biochem J 304(pt 2):509–516, 1994

    Google Scholar 

  23. Chan WK, Decker EA, Chow CK, Biossonnealut GA: Effect of dietary carnosine on plasma and tissue antioxidant concentration and on lipid oxidation in rat skeletal muscle. Lipids 29(7):461–466, 1994

    Google Scholar 

  24. Kukreja RC, Hess ML: The oxygen free radical system: from equations through membrane-protein interactions to cardiovascular injury and protection. Cardiovasc Res 26(7):641–655, 1992

    Google Scholar 

  25. Patel M, Day BJ: Metalloporphyrin class of therapeutic catalytic antioxidants. Trends Pharmacol Sci 20:359–364, 1999

    Google Scholar 

  26. Day BJ, Batinic-Haberle I, Crapo JD: Metalloporphyrins are potent inhibitors of lipid peroxidation. Free Radic Biol Med 26:730–736, 1999

    Google Scholar 

  27. Udilova N, Popov IN, Levin GI, Vladimirov IA: Antioxidant properties of UC irradiated blood plasma as determined by the photochemiluminescence method. Biofizika 42(1):187–190, 1997

    Google Scholar 

  28. Yokoyama H, Horie T, Awazu S: Lipid peroxidation and chemiluminescence during naproxen metabolism in rat liver microsomes. Hum & Exp Toxicol 13(12):831–838, 1994

    Google Scholar 

  29. Kirsner JB, Shorter RG: Recent developments in “nonspecific” inflammatory bowel disease. N Engl J Med 306:837–848, 1982

    Google Scholar 

  30. Sharon P, Stenson WF: Metabolism of arachonic acid in acetic acid. Similarity to human inflammatory bowel disease. Gastroenterology 88:55–63, 1985

    Google Scholar 

  31. Hodgson HJF, Jewell DP: The humoral immune system in inflammatory bowel disease. Am J Dig Dis 23:123–128, 1978

    Google Scholar 

  32. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL: Hapten induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96:795–803, 1989

    Google Scholar 

  33. Repine JE, Eaton JW, Anders MW, Hoidal JR, Fox RB: Generation of hydroxyl radical by enzymes, chemicals and human phagocytes in vitro. Detection with the anti-inflammatory agent dimethyl sulphoxide. J Clin Invest 64:1642–1651, 1979

    Google Scholar 

  34. Fitzpatrick LR, Bostwick JS, Renzetti M, Pendleton RG, Decktor DL: Antiinflammatory effects of various drugs on acetic acid induced colitis in the rat. Agents Actions. 30(3-4): 393–402, 1990

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Choudhary, S., Keshavarzian, A., Yong, S. et al. Novel Antioxidants Zolimid and AEOL11201 Ameliorate Colitis in Rats. Dig Dis Sci 46, 2222–2230 (2001). https://doi.org/10.1023/A:1011975218006

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1011975218006

Navigation